Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -27.84-15.3241.0512.11166.14

What is the latest EBIT Growth ratio of SUVEN PHARMACEUTICALS ?

The latest EBIT Growth ratio of SUVEN PHARMACEUTICALS is -27.84 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-27.84
Mar2023-15.32
Mar202241.05
Mar202112.11
Mar2020166.14

How is EBIT Growth of SUVEN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -27.84
Negative
Mar2023 -15.32
Negative
Mar2022 41.05
238.98
Mar2021 12.11
-92.71
Mar2020 166.14 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹41,259.6 Cr 1.8% 2.5% 67.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -3.3% 3.4% 13.9% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 4.1% 15.2% 60.2% Stock Analytics
CIPLA ₹121,328.0 Cr 0.6% 5.6% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 1.9% 3.7% 28.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.2% 11.4% 2.6% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

1.8%

2.5%

67.8%

SENSEX

0.7%

9.6%

10.7%


You may also like the below Video Courses